Literature DB >> 15971052

[Acute cerebral circulation problems].

P D Schellinger1, R Kollmar, U K Meyding-Lamadé, J B Fiebach, W Hacke.   

Abstract

Acute stroke is the third most common cause of death and also the most common cause of permanent disability in industrialized countries. Ischemic stroke is caused by occlusion of a cerebral artery leading to a critical reduction in brain perfusion in the respective brain area (penumbra). Most acute stroke treatment strategies are based on the penumbra concept: attaining rapid and persistent reperfusion is followed by the protection of critically ischemic and not yet infarcted (penumbral) tissue by, e.g., neuroprotection. Examination of the acute stroke patient includes a brief history, neurostatus and imaging (CT or MRI) for the exclusion of intracerebral hemorrhage. The diagnostic standard is CT; modern stroke MRI protocols provide an improved selection in later time windows. Intravenous thrombolysis with rt-PA within 3 h of symptom onset is the only approved therapy with a proven significant benefit for the patient. The effect is smaller but still significant if treatment occurs up to 4.5 h, and may still be present in MRI selected patients up to 9 h. More aggressive forms of therapy include interventional reperfusion techniques and therapy of malignant MCA infarction such as hemicraniectomy and hypothermia, which at present, however, are not routine and are only performed in specialized centers.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15971052     DOI: 10.1007/s00108-005-1449-y

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  25 in total

1.  European Stroke Initiative Recommendations for Stroke Management-update 2003.

Authors:  Tom Skyhoj Olsen; Peter Langhorne; Hans Christoph Diener; Michael Hennerici; Jose Ferro; Johani Sivenius; Nils Gunnar Wahlgren; Philip Bath
Journal:  Cerebrovasc Dis       Date:  2003       Impact factor: 2.762

2.  Historical perspective.

Authors:  J P Mohr
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

3.  Acute stroke: usefulness of early CT findings before thrombolytic therapy.

Authors:  R von Kummer; K L Allen; R Holle; L Bozzao; S Bastianello; C Manelfe; E Bluhmki; P Ringleb; D H Meier; W Hacke
Journal:  Radiology       Date:  1997-11       Impact factor: 11.105

4.  Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study.

Authors:  P L Kolominsky-Rabas; M Weber; O Gefeller; B Neundoerfer; P U Heuschmann
Journal:  Stroke       Date:  2001-12-01       Impact factor: 7.914

Review 5.  [Thrombolysis in cerebral ischemia. An overview].

Authors:  P D Schellinger; J Fiebach; P A Ringleb; O Jansen; W Hacke
Journal:  Nervenarzt       Date:  2001-08       Impact factor: 1.214

Review 6.  [Modern magnetic resonance techniques in stroke].

Authors:  J B Fiebach; P D Schellinger
Journal:  Radiologe       Date:  2003-03       Impact factor: 0.635

7.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

Authors:  Werner Hacke; Greg Albers; Yasir Al-Rawi; Julien Bogousslavsky; Antonio Davalos; Michael Eliasziw; Michael Fischer; Anthony Furlan; Markku Kaste; Kennedy R Lees; Mariola Soehngen; Steven Warach
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

Review 8.  Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

Authors:  Gregory W Albers; Pierre Amarenco; J Donald Easton; Ralph L Sacco; Philip Teal
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

9.  Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction.

Authors:  S Schwab; S Schwarz; M Spranger; E Keller; M Bertram; W Hacke
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

10.  Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

Authors:  Werner Hacke; Geoffrey Donnan; Cesare Fieschi; Markku Kaste; Rüdiger von Kummer; Joseph P Broderick; Thomas Brott; Michael Frankel; James C Grotta; E Clarke Haley; Thomas Kwiatkowski; Steven R Levine; Chris Lewandowski; Mei Lu; Patrick Lyden; John R Marler; Suresh Patel; Barbara C Tilley; Gregory Albers; Erich Bluhmki; Manfred Wilhelm; Scott Hamilton
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.